Case number 1:21-cv-01656
Novartis Pharmaceuticals Corporation v. Sun Pharmaceutical Industries Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 20, 2023 | 100 | Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 04/20/2023) (4) |
| Apr 19, 2023 | 99 | STIPULATION of Dismissal by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 04/19/2023) (2) |
| Apr 12, 2023 | 98 | NOTICE to Take Deposition of Steven A. Boyd, Ph.D. on April 17, 2023 filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) (Entered: 04/12/2023) (2) |
| Apr 3, 2023 | 97 | NOTICE to Take Deposition of Steven Little, Ph.D. on April 6, 2023 filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) (Entered: 04/03/2023) (2) |
| Mar 13, 2023 | 96 | NOTICE to Take Deposition of Paul Laskar, Ph.D. [AMENDED] on March 16, 2023 filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) (Entered: 03/13/2023) (2) |
| Mar 8, 2023 | 95 | NOTICE to Take Deposition of Paul Laskar, Ph.D. on March 16, 2023 filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) (Entered: 03/08/2023) (2) |
| Mar 6, 2023 | 94 | NOTICE OF SERVICE of Defendants' Reply Expert Report of Paul A. Laskar, Ph.D. on Patent Invalidity filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) (Entered: 03/06/2023) (3) |
| Feb 10, 2023 | 93 | STIPULATION TO EXTEND TIME See Stip for Details to - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 02/10/2023) (3) |
| Feb 8, 2023 | 92 | ORAL ORDER: Having reviewed the parties' Stipulation and [Proposed Order] to Extend Time (D.I. 167), the requested extensions do not leave sufficient time for the Court to review, evaluate and issue opinions on Daubert motion(s) before the Pretrial Conference and Trial currently scheduled for June 5, 2023 and June 12, 2023 respectively. If Court grants the requested extensions, the Court will need to reschedule the Pretrial Conference and Trial to later available dates in 2023 or 2024. Alternatively, the Court can accommodate an extension to the Daubert motion deadline to April 17, 2023. Therefore, IT IS HEREBY ORDERED THAT, on or before Friday, February 10, 2023, the parties should advise the Court whether they still want the requested extension of deadlines or otherwise file a revised stipulation extending the deadline for Daubert motions to April 17, 2023 and adjusting other deadlines accordingly. ORDERED by Judge Gregory B. Williams on 2/8/23. Associated Cases: 1:20-cv-01426-GBW, 1:21-cv-01656-GBW (ntl) (Entered: 02/08/2023) (0) |
| Feb 6, 2023 | 91 | STIPULATION TO EXTEND TIME (1) Reply Expert Reports, (2) Close of Expert Discovery, and (3) Deadline for Daubert Motions to (1) March 3, 2023, (2) April 17, 2023, and (3) April 24, 2023 - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 02/06/2023) (2) |
| Jan 23, 2023 | 90 | NOTICE OF SERVICE of (1) Responsive Expert Report of Dr. Steven Boyd; (2) Responsive Expert Report of Dr. Christopher Vellturo; (3) Responsive Expert Report of Dr. Steven Little; (4) Responsive Expert Report of Dr. Alan Myerson; and (5) Responsive Expert Report of Dr. Stephen Pflugfelder, and supporting documents filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) (Entered: 01/23/2023) (3) |
| Jan 10, 2023 | 89 | STIPULATION TO EXTEND TIME See Stip for Details to - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 01/10/2023) (2) |
| Dec 6, 2022 | 88 | SCHEDULING ORDER (See Order for further details). Signed by Judge Gregory B. Williams on 12/6/22. Associated Cases: 1:20-cv-01426-GBW, 1:21-cv-01656-GBW (ntl) (Entered: 12/06/2022) (13) |
| Nov 10, 2022 | 87 | PROPOSED ORDER Scheduling (ANDA) by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 11/10/2022) (13) |
| Nov 7, 2022 | 84 | NOTICE OF SERVICE of Defendants Aurobindo, Micro labs and Sun's Opening Expert Report of Robert Cykiert, M.D. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) (Entered: 11/07/2022) (2) |
| Nov 7, 2022 | 85 | NOTICE OF SERVICE of Expert Report of Pat N. Confalone, Ph.D. Regarding Invalidity of U.S. Patent Nos. 7,314,938; 7,790,743; 8,168,655; 8,084,047; 8,592,450; 8,367,701; and 9,447,077 filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) (Entered: 11/07/2022) (2) |
| Nov 7, 2022 | 86 | NOTICE OF SERVICE of Defendants' Opening Expert Report of Paul A. Laskar, Ph.D. on Patent Invalidity filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) (Entered: 11/07/2022) (3) |
| Nov 1, 2022 | 83 | Letter to The Honorable Gregory B. Williams from Daniel M. Silver, Esq.. (Silver, Daniel) (Entered: 11/01/2022) (1) |
| Oct 28, 2022 | 82 | NOTICE OF SERVICE of Plaintiff's Final Validity Contentions Regarding U.S. Patent No. 7,314,938; U.S. Patent No. 7,790,743; U.S. Patent No. 8,168,655; U.S. Patent No. 8,084,047; U.S. Patent No. 8,592,450; U.S. Patent No. 8,367,701; U.S. Patent No. 9,447,077; and U.S. Patent No. 11,058,677 filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) (Entered: 10/28/2022) (4) |
| Oct 18, 2022 | 81 | STIPULATION TO EXTEND TIME See Stip for Details to - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 10/18/2022) (3) |
| Sep 23, 2022 | 80 | NOTICE OF SERVICE of Defendants' Joint Final Invalidity Contentions Regarding U.S. Patent No. 7,314,938; U.S. Patent No. 7,790,743; U.S. Patent No. 8,168,655; U.S. Patent No. 8,084,047; U.S. Patent No. 8,592,450; U.S. Patent No. 8,367,701; U.S. Patent No. 9,447,077; and U.S. Patent No. 11,058,677 filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) (Entered: 09/23/2022) (2) |
| Sep 16, 2022 | 79 | STIPULATION and [Proposed] Order by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 09/16/2022) (4) |
| Sep 9, 2022 | 78 | NOTICE to Take Deposition of Dr. Tom Gadek (Amended) on September 14, 2022 filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) (Entered: 09/09/2022) (4) |
| Sep 8, 2022 | 77 | STIPULATION and [Proposed] Order by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 09/08/2022) (3) |
| Sep 6, 2022 | 75 | NOTICE to Take Deposition of Mary Newman on September 8, 2022 filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) (Entered: 09/06/2022) (4) |
| Sep 6, 2022 | 76 | ANSWER to Amended Complaint, re: 69 Amended Complaint, by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) (Entered: 09/06/2022) (30) |
| Sep 1, 2022 | 73 | STIPULATION TO EXTEND TIME Joint Letter Regarding Any Additional Claim Construction Issues to October 18, 2022 - filed by Micro Labs Limited, Micro Labs USA Inc.. (Haney, Megan) (Entered: 09/01/2022) (3) |
| Sep 1, 2022 | 74 | SO ORDERED re (143 in 1:20-cv-01426-MN, 73 in 1:21-cv-01656-MN) STIPULATION TO EXTEND TIME to file Joint Letter Regarding Any Additional Claim Construction Issues to October 18, 2022 for the Micro Labs and Aurobindo Defendants. Signed by Judge Maryellen Noreika on 9/1/2022. (dlw) (Entered: 09/01/2022) (3) |
| Aug 25, 2022 | 72 | SO ORDERED re 71 Stipulation and Order Dismissing Complaint as to Defendant Sun Pharma Global FZE and Amendment of Caption. Party Sun Pharma Global FZE terminated. Attorney R. Touhey Myer; Michael P. Hogan and Timothy H. Kratz terminated as to this Defendant. Signed by Judge Maryellen Noreika on 8/25/2022. (dlw) (Entered: 08/25/2022) (4) |
| Aug 24, 2022 | 70 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,058,677; 8,927,574; 9,353,088; 9,890,141; 9,085,553; 7,314,938; 7,745,460; 7,790,743; 7,928,122; 9,216,174; 10,124,000; 8,084,047; 8,592,450; 8,168,655; 8,367,701; 9,447,077. (Attachments: # 1 Report PTO Attachment)(Joyce, Alexandra) Modified on 8/24/2022 (dlw). (Entered: 08/24/2022) (Main Document) (1) |
| Aug 24, 2022 | 71 | STIPULATION and [Proposed] Order Dismissing Complaint as to Defendant Sun Pharma Global FZE and Amendment of Caption by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 08/24/2022) (4) |
| Aug 24, 2022 | 70 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,058,677; 8,927,574; 9,353,088; 9,890,141; 9,085,553; 7,314,938; 7,745,460; 7,790,743; 7,928,122; 9,216,174; 10,124,000; 8,084,047; 8,592,450; 8,168,655; 8,367,701; 9,447,077. (Attachments: # 1 Report PTO Attachment)(Joyce, Alexandra) Modified on 8/24/2022 (dlw). (Entered: 08/24/2022) (Report PTO Attachment) (1) |
| Aug 23, 2022 | 69 | Amended Complaint* (1) |
| Jul 27, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER re (132 in 1:20-cv-01426-MN, 61 in 1:21-cv-01656-MN) Stipulation and Proposed Order - WHEREAS, the parties have submitted a proposed stipulation that includes, inter alia, new pre-trial deadlines that extend Daubert briefing but keep the existing pretrial conference and trial dates; WHEREAS, should this case proceed to trial, it will be a bench trial (see D.I. 93 in C.A. No. 20-1426 and D.I. 18 in C.A. No. 21-1656); WHEREAS, "[w]hen the role of the gatekeeper to admit or exclude evidence (the judge) and the role of the factfinder to assess and weigh the evidence... (the jury) are one and the same, the judge who becomes the factfinder as well as the gatekeeper... should not be required to waste judicial time" In re Unisys, 173 F.3d 145, 155-58 (3d Cir. 1999); and WHEREAS, the Court can better address Daubert issues in context at trial when the Court can hear testimony and better understand the bases for the experts' opinions. THEREFORE, IT IS HEREBY ORDERED that, should any party wish to file Daubert motions, they shall file a letter seeking permission to do so. Opening letter briefs shall be no longer than three (3) pages and shall be filed with the Court on or before 3/31/2023. Answering letter briefs shall be no longer than three (3) pages and shall be filed with the Court no later than seven (7) days after the filing of the opening letter briefs. No replies shall be filed. Unless the Court grants leave for additional letters to be filed, each side shall present all grounds on which it seeks permission to file Daubert motions in its single opening letter brief. IT IS FURTHER ORDERED that the parties shall submit an updated stipulation including the above provisions for the Court's consideration. ORDERED by Judge Maryellen Noreika on 7/27/2022. (dlw) |
| Jul 27, 2022 | 63 | Main Document (3) Docket Text: STIPULATION and [Proposed] Order by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A)(Joyce, Alexandra) |
| Jul 27, 2022 | 63 | Exhibit A (2) |
| Jul 27, 2022 | 64 | SO ORDERED (5) Docket Text: SO ORDERED re (63 in 1:21-cv-01656-MN, 134 in 1:20-cv-01426-MN) Stipulation and Order (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 9/14/2022. Opening Expert Reports due by 10/24/2022. Rebuttal Expert Reports due by 12/22/2022. Reply Expert Report due by 1/20/2023. Expert Discovery due by 3/24/2023). SEE STIPULATION FOR FURTHER AND COMPLETE DETAILS. Signed by Judge Maryellen Noreika on 7/27/2022. (dlw) |
| Jul 26, 2022 | 61 | Main Document (3) Docket Text: STIPULATION and [Proposed] Order by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A)(Joyce, Alexandra) |
| Jul 26, 2022 | 61 | Exhibit A (1) |
| Jul 22, 2022 | 59 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Isabelle Jensen as co-counsel.. (Joyce, Alexandra) |
| Jul 22, 2022 | 60 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendants Amended First Common Interrogatories (Nos. 1-3) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jul 15, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (57 in 1:21-cv-01656-MN, 128 in 1:20-cv-01426-MN) STIPULATION TO EXTEND TIME for the Close of Fact Discovery to July 20, 2022 filed by Novartis Pharmaceuticals Corporation, Set/Reset Scheduling Order Deadlines: ( Fact Discovery completed by 7/20/2022). ORDERED by Judge Maryellen Noreika on 7/15/2022. Associated Cases: 1:20-cv-01426-MN, 1:21-cv-01656-MN(mdb) |
| Jul 15, 2022 | 57 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the Close of Fact Discovery to July 20, 2022 - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Jul 15, 2022 | 58 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendants' Amended First Set of Requests for Production (Nos. 1-96) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jul 8, 2022 | 56 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Objections and Responses to Sun Defendants' First Set of Interrogatories (Nos. 1-2), and (2) Plaintiff's Objections and Responses to Defendants' First Set of Requests for Production (Nos. 1-71) filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Jul 6, 2022 | 55 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Mary Newman on July 15, 2022 filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Hitch, Cortlan) |
| Jun 24, 2022 | 54 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Sun Pharmaceutical Industries Limited, Sun Pharmaceuticals Industries, Inc. and Sun Pharma Global FZE's Responses and Objections to Plaintiff's Notice of 30(b)(6) Deposition of Sun Defendants filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) |
| Jun 21, 2022 | 33 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Christopher M. Adams filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 34 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Kenneth Barr filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 35 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of John Burnier filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 36 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Thomas Gadek filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 37 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of William Hunke filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 38 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Wang Shen filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 39 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of James Robert Zeller filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 40 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Mark Bridle filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 41 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Adarsh Jain filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 42 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Harnam Singh filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 43 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of T. Jagdeeswar Rao filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 44 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Karunakaran Gandam filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 45 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Muthukumaran N filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 46 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Dr. Neela Praveen Kumar filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 47 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Pramod Kumar filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 48 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Dr. Praveen Varma filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 49 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Sureka Khopade filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 50 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Surekha Kopade filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 51 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Sujeet Shrivastava filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 52 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Vinita Chandrawanshi filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 53 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff Novartis Pharmaceuticals Corporation's Amended Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 15, 2022 | 31 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendants' Notice of Deposition of Plaintiff Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 15, 2022 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Aurobindo, Micro Labs, and Sun's Amended First Set of Joint Requests for Production to Plaintiffs (Nos. 1-96) and; (2) Defendants Aurobindo, Micro Labs, and Sun's Amended First Set of Interrogatories to Plaintiffs (Nos. 1-3) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 13, 2022 | 30 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Notice of 30(b)(6) Deposition of Defendants Sun filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 3, 2022 | 29 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Plaintiff Novartis Pharmaceuticals Corporation Pursuant to Fed. R. Civ. P. 30(b)(6) on June 23, 2022 filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) |
| Jun 1, 2022 | 28 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Sun Pharmaceutical Industries, Ltd., Sun Pharmaceutical Industries, Inc. and Sun Pharma Global FZE's First Set of Interrogatories to Plaintiff (Nos. 1-2) and Sun Pharmaceutical Industries, Ltd., Sun Pharmaceutical Industries, Inc. and Sun Pharma Global FZE's First Set of Requests for Production of Documents and Things to Plaintiff (Nos. 1-71) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) |
| May 25, 2022 | 27 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.and Sun Pharma Global FZE's Responses and Objections to Plaintiff's First Set of Interrogatories (Nos. 1-4) and Defendants, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.and Sun Pharma Global FZE's Responses and Objections to Plaintiff's First Set of Requests for Production (Nos. 1-58) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) |
| May 19, 2022 | 26 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.and Sun Pharma Global FZE's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) |
| May 16, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Isabelle Jensen and Jessamyn S. Berniker for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 16, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Bruce R. Genderson for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| May 16, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher J. Mandernach for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| May 16, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Angela X. Gao for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 13, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [25] MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Christopher J. Mandernach, Kathryn E. Garza, Angela X. Gao, and Isabelle Jensen filed by Novartis Pharmaceuticals Corporation. ORDERED by Judge Maryellen Noreika on 5/13/2022. (mdb) |
| May 12, 2022 | 25 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Christopher J. Mandernach, Kathryn E. Garza, Angela X. Gao, and Isabelle Jensen - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Certifcations for Bruce R. Genderson, Jessamyn S. Berniker, Christopher J. Mandernach, Kathryn E. Garza, Angela X. Gao, and Isabelle Jensen)(Joyce, Alexandra) |
| May 12, 2022 | 25 | Certifcations for Bruce R. Genderson, Jessamyn S. Berniker, Christopher J. Mand (6) |
| Apr 29, 2022 | 23 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Alexandra M. Joyce (Joyce, Alexandra) |
| Apr 29, 2022 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.and Sun Pharma Global FZE's Initial Invalidity Contentions Regarding U.S. Patent Nos. 8,927,574; 9,085,553; 9,353,088; 9,890,141 AND 11,058,677 and References filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) |
| Apr 28, 2022 | 22 | SO ORDERED (3) Docket Text: SO ORDERED re (21 in 1:21-cv-01656-MN, 94 in 1:20-cv-01426-MN) Stipulation and Order Regarding the Protective Order. Signed by Judge Maryellen Noreika on 4/28/2022. (dlw) |
| Apr 27, 2022 | 21 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding the Protective Order by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Apr 25, 2022 | 19 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Novartis Pharmaceuticals Corporation's Fed. R. Civ. P. 26(a)(1) Initial Disclosures; (2) Plaintiff's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; (3) Plaintiff's First Set of Requests for Production to Defendants Sun Pharmaceuticals Industries, Ltd., Sun Pharmaceuticals Industries Inc., and Sun Pharma Global FZE (Nos. 1-58); and (4) Plaintiff's First Set of Interrogatories (Nos. 1-4) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Apr 25, 2022 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.and Sun Pharma Global FZE's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) |
| Apr 19, 2022 | 18 | Scheduling Order (13) Docket Text: SCHEDULING ORDER: Joinder of Parties due by 7/1/2022. Amended Pleadings due by 7/1/2022. Fact Discovery completed by 7/15/2022. Opening Expert Reports due by 9/9/2022. Rebuttal Expert Reports due by 11/8/2022. Reply Expert Reports due by 12/9/2022. Expert Discovery due by 3/10/2023. A Pretrial Conference is set for 6/5/2023 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 6/12/2023 at 08:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 4/19/2022. (dlw) |
| Apr 14, 2022 | 17 | Proposed Order (13) Docket Text: PROPOSED ORDER // Scheduling Order by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc. (Myer, R.) Modified on 4/18/2022 (dlw). |
| Apr 11, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (91 in 1:20-cv-01426-MN, 16 in 1:21-cv-01656-MN) STIPULATION TO EXTEND TIME to Submit Proposed Revised Scheduling Order to April 14, 2022. ORDERED by Judge Maryellen Noreika on 4/11/2022. (dlw) |
| Apr 8, 2022 | 15 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Claim Charts To Defendants Sun Pharmaceuticals Industries, Ltd., Sun Pharmaceuticals Industries Inc., and Sun Pharma Global FZE filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Apr 8, 2022 | 16 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Revised Scheduling Order to April 14, 2022 - filed by Micro Labs Limited, Micro Labs USA Inc.. (Phillips, John) |
| Apr 4, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (88 in 1:20-cv-01426-MN, 14 in 1:21-cv-01656-MN) STIPULATION TO EXTEND TIME to submit a revised scheduling order to April 8, 2022 filed by Micro Labs USA Inc., Micro Labs Limited. ORDERED by Judge Maryellen Noreika on 4/4/2022. Associated Cases: 1:20-cv-01426-MN, 1:21-cv-01656-MN(mdb) |
| Apr 1, 2022 | 14 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a revised scheduling order to April 8, 2022 - filed by Micro Labs Limited, Micro Labs USA Inc.. (Phillips, John) |
| Mar 21, 2022 | 12 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' documents at bates range SUN_LIFIT00000001 - SUN_LIFIT_00014255 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) |
| Mar 21, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that, within thirty (30) days from the date of this Order, the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, which is also consistent with the following guidance. This case shall proceed on the same schedule as related case C.A. No. 20-1426 including the pretrial conference (6/5/2023 at 4:30 PM) and trial (6/12/2023). The parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes (i.e., several weeks prior to or after the deadline to complete fact discovery). The parties shall review the claim construction order entered by Judge Stark in the related case (D.I. 79 in C.A. No. 20-1426) and if they believe that additional terms need to be construed, they shall so advise the Court. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms). If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 3/21/2022. (dlw) |
| Mar 11, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:20-cv-01426-MN, 1:21-cv-00969-MN, 1:21-cv-01656-MN (rjb) |
| Jan 26, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz and Michael P. Hogan filed by Sun Pharmaceutical Industries, Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd. Signed by Judge Leonard P. Stark on 1/26/22. (ntl) |
| Jan 26, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Timothy H. Kratz,Michael P. Hogan for Sun Pharma Global FZE,Sun Pharmaceutical Industries Ltd.,and Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| Jan 26, 2022 | 11 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz and Michael P. Hogan - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Myer, R.) |
| Jan 21, 2022 | 9 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) |
| Jan 21, 2022 | 10 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceuticals Industries Ltd. for Sun Pharmaceutical Industries, Inc. filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Myer, R.) |
| Dec 2, 2021 | 6 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Sun Pharmaceutical Industries Ltd. waiver sent on 11/30/2021, answer due 1/31/2022. (Silver, Daniel) |
| Dec 2, 2021 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Sun Pharma Global FZE waiver sent on 11/30/2021, answer due 1/31/2022. (Silver, Daniel) |
| Dec 2, 2021 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Sun Pharmaceutical Industries, Inc. waiver sent on 11/30/2021, answer due 1/31/2022. (Silver, Daniel) |
| Dec 1, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Nov 23, 2021 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (twk) |
| Nov 23, 2021 | 1 | Main Document (29) Docket Text: COMPLAINT filed against Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3749885.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-E, # (2) Civil Cover Sheet)(twk) |
| Nov 23, 2021 | 1 | Exhibit A-E (364) |
| Nov 23, 2021 | 1 | Civil Cover Sheet (2) |
| Nov 23, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Nov 23, 2021 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 16, 2020 and October 11, 2021. Date of Expiration of Patent: December 18, 2033 (11,058,677); November 12, 2030 (8,927,574); October 21, 2030 (9,353,088); October 21, 2030 (9,890,141); July 25, 2033 (9,085,553). Thirty Month Stay Deadline: 1/11/2024. (twk) |
| Nov 23, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,058,677; 8,927,574; 9,353,088; 9,890,141; 9,085,553. (twk) |
| Nov 23, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (twk) |
| Nov 23, 2021 | 1 | Complaint* (1) |
